NCT02342184View on ClinicalTrials.gov

Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Guillain-Barré Syndrome
Interventions
DRUG

GB-0998

Trial Locations (1)

Unknown

Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe

Sponsors
All Listed Sponsors
lead

Japan Blood Products Organization

INDUSTRY